Genetic Signatures Ltd has released a press release.
Genetic Signatures completes $35m placement
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
In the deck
Earlier from Genetic Signatures
- Appendix 4E & Full Year Statutory Accounts
- Appendix 4C and quarterly update
- TGA registration for Respiratory Pathogen Detection Kit
- Appendix 4C - quarterly
- CE-IVD Mark for Respiratory Pathogen Detection Kit
Later from Genetic Signatures
- Investor presentation - capital raise
- Appendix 4C & quarterly report
- Pause in Trading
- First shipments and regulatory submissions for COVID-19 test
- CE-IVD received for COVID-19 test
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures